A New Combination of Evidence-Based Interventions to Improve Primary Care Diagnostic Safety and Efficiency
NCT05735314 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 450
Last updated 2025-12-30
Summary
The purpose of this study is to measure the evidence-based intervention's (EBIs) impact on patient safety and efficiency, to assess the EBIs implementation by measuring acceptability, appropriateness, cost, fidelity, penetration, and sustainability and to identify the facilitators and barriers that influence the degree of implementation of these EBIs.
Conditions
- Anemia
- Decreased Glomerular Filtration Rate
Interventions
- OTHER
-
Enhanced diagnostic team implementing three evidence-based interventions
we designed an enhanced team process entailing: 1) using automated abnormal test result detection and tracking; 2) expanding the primary care team to include CPs to guide the evaluation of anemia to identify underlying causes; and 3) using NNs to engage patients in the healthcare team and diagnostic process and increase patient activation.
- OTHER
-
Usual care
Usual care involves primary care physicians ordering additional tests and referrals to evaluate patients with new anemia and decreased glomerular filtration rate (GFR) .
Sponsors & Collaborators
-
The University of Texas Health Science Center, Houston
lead OTHER
Principal Investigators
-
Eric Thomas, MD,MPH · The University of Texas Health Science Center, Houston
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-01-08
- Primary Completion
- 2026-07-16
- Completion
- 2026-07-16
Countries
- United States
Study Locations
More Related Trials
-
A Phase 2 Extension Study of Study GCS-100-CS-4002
NCT02155673 ·Status: COMPLETED ·Phase: PHASE2
-
PA21 Phase II Clinical Study in Hemodialysis Patients With Hyperphosphatemia
NCT01521494 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Evaluation of the Incidence of NSF in Patients With Kidney Disease Undergoing MR
NCT01135316 ·Status: COMPLETED
-
Safety of Single Doses of Peginesatide in Patients With Chronic Kidney Disease
NCT00109291 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of Pharmacokinetics and Safety of LY3537031 in Participants With Normal Renal Function and Participants With Renal Impairment
NCT07165015 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Study of Alpha-Melanocyte Stimulating Hormone in Patients With Acute Renal Failure
NCT00004496 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluate the Efficacy and Safety of ABP-671 in Subjects With Chronic Kidney Disease and Hyperuricaemia
NCT07323095 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of the Treatment of Primary Membranous Nephropathy: A Randomized Clinical Trial
NCT05532111 ·Status: UNKNOWN ·Phase: NA
-
A Study of Roxadustat for the Treatment of Anemia in Participants With Chronic Kidney Disease and Not Receiving Dialysis
NCT01750190 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study for AKB-6548 in Participants With Chronic Kidney Disease and Anemia
NCT01235936 ·Status: COMPLETED ·Phase: PHASE2
-
Pentoxifylline and Progression of Chronic Kidney Disease in Moderate-to-high Risk Patients
NCT00285298 ·Status: COMPLETED ·Phase: PHASE3
-
Study Assessing PK and Safety of MGTA-145 in Subjects With Normal Estimated GFR and Varying Degrees of Renal Impairment
NCT04154670 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of KP104
NCT05476887 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerability, And Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease on Hemodialysis.
NCT01146574 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability, PK & PD Study of JTZ-951 in Anemic Subjects With End-stage Renal Disease
NCT01971164 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, and Effects on Blood and Urine Markers of Single Ascending Dose of GSK4771261 in Healthy Participants and Participants With Autosomal Dominant Polycystic Kidney Disease
NCT06734234 ·Status: RECRUITING ·Phase: PHASE1
-
A Research Study of How the Medicine Ziltivekimab Works in the Body of Chinese Men and Women With Kidney Disease and Inflammation
NCT05379829 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of KDSTEM Inj. in Patients With Chronic Kidney Disease
NCT06071143 ·Status: RECRUITING ·Phase: PHASE1
-
Phase 1 Study to Assess the Safety, PK and PD of INBRX-101 in Adults With Alpha-1 Antitrypsin Deficiency
NCT03815396 ·Status: COMPLETED ·Phase: PHASE1
-
Low Phosphate Diets in Patients With Early Stages of Chronic Kidney Disease
NCT00438932 ·Status: COMPLETED ·Phase: NA
-
Open-Label Study To Evaluate the Safety and Efficacy of the Renal Assist Device In Patients With Acute Renal Failure
NCT00511407 ·Status: COMPLETED ·Phase: PHASE2
-
A First-in-Human Safety and Efficacy Study of ALN-CFB, a Small Interfering RNA (siRNA) Targeting Complement Factor B, in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria With Persistent Anemia on a C5 Inhibitor
NCT07187401 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease
NCT05951192 ·Status: COMPLETED ·Phase: PHASE4
-
Study of APX-115 in Contrast Induced Acute Kidney Injury in Subjects Undergoing PCI
NCT05758896 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Phase 2a Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease
NCT01843790 ·Status: COMPLETED ·Phase: PHASE2